Interlace Trial
Induction chemotherapy followed by chemoradiotherapy significantly improves both progression-free survival and overall survival in patients with locally advanced cervical cancer compared to chemoradiotherapy alone.
Shitanshu Uppal
Publications Update # 77
Living Room - Podcast Episode from Love+Radio, Keynote B21 trial and a video discussion of the trial and Compassion 16 trial in cervical cancer
COMPASSION-16: Cadonilimab for Persistent, Recurrent, or Metastatic Cervical Cancer
Cadonilimab potentially offers better PFS than pembrolizumab and atezolizumab therapies in recurrent advanced metastatic cervical cancer
Publications Update # 76
Focused Topic: Gestational Trophoblastic Neoplasia.
Gestational Trophoblastic Disease: Part 1
Publications Update # 75
Anthropocene Reviewed Podcast, tryanny of non-inferiority trials and a mini-tutorial on non-inferiority trials, GY-005 results, ENGOT-OV41 ANITA trial
Mucinous Ovarian Carcinoma
mEOC/GOG-0241: Oxaliplatin-Capecitabine vs. Carboplatin-Paclitaxel in Mucinous Epithelial Ovarian Cancer
Neither oxaliplatin-capecitabine nor bevacizumab significantly improved OS or PFS compared to paclitaxel-carboplatin in advanced-stage mucinous ovarian cancer.
Vulvar Melanoma
Publications Update # 74
FIGO 2023 staging system for endometrial cancer - a deep dive.